Literature DB >> 25060581

Immune modulation by butyrophilins.

Heather A Arnett1, Joanne L Viney2.   

Abstract

The B7 family of co-stimulatory molecules has an important role in driving the activation and inhibition of immune cells. Evolving data have shown that a related family of molecules - the butyrophilins - have similar immunomodulatory functions to B7 family members and may represent a novel subset of co-stimulatory molecules. These studies have taken the field by surprise, as the butyrophilins were previously thought to only be important in lactation and milk production. In this Review, we describe the expression patterns of the various members of the butyrophilin family and explore their immunomodulatory functions. In particular, we emphasize the contribution of butyrophilins to immune homeostasis and discuss the potential of targeting these molecules for therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25060581     DOI: 10.1038/nri3715

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  88 in total

1.  Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations.

Authors:  Yoshiji Yamada; Tamotsu Nishida; Sahoko Ichihara; Motoji Sawabe; Noriyuki Fuku; Yutaka Nishigaki; Yukitoshi Aoyagi; Masashi Tanaka; Yoshinori Fujiwara; Hiroto Yoshida; Shoji Shinkai; Kei Satoh; Kimihiko Kato; Tetsuo Fujimaki; Kiyoshi Yokoi; Mitsutoshi Oguri; Tetsuro Yoshida; Sachiro Watanabe; Yoshinori Nozawa; Aki Hasegawa; Toshio Kojima; Bok-Ghee Han; Younjin Ahn; Meehee Lee; Dong-Jik Shin; Jong Ho Lee; Yangsoo Jang
Journal:  Atherosclerosis       Date:  2010-12-15       Impact factor: 5.162

2.  Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex.

Authors:  Adrian P Scott; Nigel G Laing; Frank Mastaglia; Merrilee Needham; Maggie C Walter; Marinos C Dalakas; Richard J N Allcock
Journal:  J Neuroimmunol       Date:  2011-05-02       Impact factor: 3.478

3.  Cloning, localization, and structure of new members of the butyrophilin gene family in the juxta-telomeric region of the major histocompatibility complex.

Authors:  R Tazi-Ahnini; J Henry; C Offer; C Bouissou-Bouchouata; I H Mather; P Pontarotti
Journal:  Immunogenetics       Date:  1997       Impact factor: 2.846

Review 4.  The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response.

Authors:  Hassnae Afrache; Philippe Gouret; Shanaiz Ainouche; Pierre Pontarotti; Daniel Olive
Journal:  Immunogenetics       Date:  2012-09-23       Impact factor: 2.846

5.  Differential role for CD277 as a co-regulator of the immune signal in T and NK cells.

Authors:  Nassima Messal; Emilie Mamessier; Aude Sylvain; Javier Celis-Gutierrez; Marie-Laure Thibult; Bruno Chetaille; Guylène Firaguay; Sonia Pastor; Yves Guillaume; Qian Wang; Ivan Hirsch; Jacques A Nunès; Daniel Olive
Journal:  Eur J Immunol       Date:  2011-11-03       Impact factor: 5.532

6.  Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74.

Authors:  M J Simmonds; J M Heward; J C Barrett; J A Franklyn; S C L Gough
Journal:  Clin Endocrinol (Oxf)       Date:  2006-10       Impact factor: 3.478

7.  Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.

Authors:  Christelle Harly; Yves Guillaume; Steven Nedellec; Cassie-Marie Peigné; Hannu Mönkkönen; Jukka Mönkkönen; Jianqiang Li; Jürgen Kuball; Erin J Adams; Sonia Netzer; Julie Déchanet-Merville; Alexandra Léger; Thomas Herrmann; Richard Breathnach; Daniel Olive; Marc Bonneville; Emmanuel Scotet
Journal:  Blood       Date:  2012-07-05       Impact factor: 22.113

8.  Association of a polymorphism of BTN2A1 with hypertension in Japanese individuals.

Authors:  Hideki Horibe; Kimihiko Kato; Mitsutoshi Oguri; Tetsuro Yoshida; Tetsuo Fujimaki; Toshiki Kawamiya; Kiyoshi Yokoi; Sachiro Watanabe; Kei Satoh; Yukitoshi Aoyagi; Masashi Tanaka; Hiroto Yoshida; Shoji Shinkai; Yoshinori Nozawa; Toyoaki Murohara; Yoshiji Yamada
Journal:  Am J Hypertens       Date:  2011-04-28       Impact factor: 2.689

9.  BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children.

Authors:  Kai-Chung Hsueh; Ying-Ju Lin; Jeng-Sheng Chang; Lei Wan; Fuu-Jen Tsai
Journal:  Eur J Pediatr       Date:  2009-11-01       Impact factor: 3.183

10.  Compartmentalization and quantitation of protein in human milk.

Authors:  B Lönnerdal; L R Woodhouse; C Glazier
Journal:  J Nutr       Date:  1987-08       Impact factor: 4.798

View more
  53 in total

1.  Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.

Authors:  Maria Raffaella Zocchi; Delfina Costa; Roberta Venè; Francesca Tosetti; Nicoletta Ferrari; Simona Minghelli; Roberto Benelli; Stefano Scabini; Emanuele Romairone; Silvia Catellani; Aldo Profumo; Alessandro Poggi
Journal:  Oncoimmunology       Date:  2017-01-06       Impact factor: 8.110

Review 2.  Human gamma delta T cells: Evolution and ligand recognition.

Authors:  Erin J Adams; Siyi Gu; Adrienne M Luoma
Journal:  Cell Immunol       Date:  2015-05-06       Impact factor: 4.868

3.  Considering B7-CD28 as a family through sequence and structure.

Authors:  Sean M West; Xiaodi A Deng
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-17

4.  BTNL2-Ig Protein Attenuates Type 1 Diabetes in Non-Obese Diabetic (NOD) Mice.

Authors:  Xiaohong Tian; Yujun Lin; Cheng Cui; Min Su; Laijun Lai
Journal:  Adv Healthc Mater       Date:  2019-03-18       Impact factor: 9.933

5.  Skint8, a Novel B7 Family-Related Molecule, Negatively Regulates T Cell Responses.

Authors:  Yujun Lin; Cheng Cui; Min Su; Xiaohong Tian; Yuanmao Huang; Jin Zhao; Laijun Lai
Journal:  J Immunol       Date:  2019-06-12       Impact factor: 5.422

Review 6.  Combination cancer immunotherapy and new immunomodulatory targets.

Authors:  Kathleen M Mahoney; Paul D Rennert; Gordon J Freeman
Journal:  Nat Rev Drug Discov       Date:  2015-08       Impact factor: 84.694

7.  Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples.

Authors:  Xuan Dung Ho; Phuong Phung; Van Q Le; Van H Nguyen; Ene Reimann; Ele Prans; Gea Kõks; Katre Maasalu; Nghi Tn Le; Le H Trinh; Hoang G Nguyen; Aare Märtson; Sulev Kõks
Journal:  Exp Biol Med (Maywood)       Date:  2017-10-19

8.  In vivo administration of recombinant BTNL2-Fc fusion protein ameliorates graft-versus-host disease in mice.

Authors:  Cheng Cui; Xiaohong Tian; Yujun Lin; Min Su; Qingquan Chen; Shao-Yuan Wang; Laijun Lai
Journal:  Cell Immunol       Date:  2018-10-26       Impact factor: 4.868

Review 9.  Butyrophilin3A proteins and Vγ9Vδ2 T cell activation.

Authors:  Siyi Gu; Marta T Borowska; Christopher T Boughter; Erin J Adams
Journal:  Semin Cell Dev Biol       Date:  2018-03-09       Impact factor: 7.727

10.  Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease.

Authors:  Fusheng Zhou; Hongzhi Cao; Xianbo Zuo; Tao Zhang; Xiaoguang Zhang; Xiaomin Liu; Ricong Xu; Gang Chen; Yuanwei Zhang; Xiaodong Zheng; Xin Jin; Jinping Gao; Junpu Mei; Yujun Sheng; Qibin Li; Bo Liang; Juan Shen; Changbing Shen; Hui Jiang; Caihong Zhu; Xing Fan; Fengping Xu; Min Yue; Xianyong Yin; Chen Ye; Cuicui Zhang; Xiao Liu; Liang Yu; Jinghua Wu; Mengyun Chen; Xuehan Zhuang; Lili Tang; Haojing Shao; Longmao Wu; Jian Li; Yu Xu; Yijie Zhang; Suli Zhao; Yu Wang; Ge Li; Hanshi Xu; Lei Zeng; Jianan Wang; Mingzhou Bai; Yanling Chen; Wei Chen; Tian Kang; Yanyan Wu; Xun Xu; Zhengwei Zhu; Yong Cui; Zaixing Wang; Chunjun Yang; Peiguang Wang; Leihong Xiang; Xiang Chen; Anping Zhang; Xinghua Gao; Furen Zhang; Jinhua Xu; Min Zheng; Jie Zheng; Jianzhong Zhang; Xueqing Yu; Yingrui Li; Sen Yang; Huanming Yang; Jian Wang; Jianjun Liu; Lennart Hammarström; Liangdan Sun; Jun Wang; Xuejun Zhang
Journal:  Nat Genet       Date:  2016-05-23       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.